Livzon Pharma to Acquire Roughly 0.13% Stake in Xinbeijiang Pharmaceutical from Zhonghuiyuan

Stock News
Nov 11

Livzon Pharma (01513) has announced that on November 11, 2026, the company entered into a share transfer agreement with Zhonghuiyuan regarding Xinbeijiang Pharmaceutical, agreeing to acquire approximately 0.13% of Xinbeijiang Pharmaceutical's shares held by Zhonghuiyuan for a cash consideration of approximately RMB 3.8525 million, corresponding to approximately RMB 303,600 of Xinbeijiang Pharmaceutical's registered capital.

Upon completion of the acquisition, the company's direct interest in Xinbeijiang Pharmaceutical will increase from approximately 90.64% to approximately 90.77%.

Zhonghuiyuan serves as an employee shareholding platform for Xinbeijiang Pharmaceutical. In order to further optimize Xinbeijiang Pharmaceutical's equity structure, strengthen the company's control over its core active pharmaceutical ingredient subsidiary, and improve operational decision-making efficiency, the company intends to acquire a portion of the Xinbeijiang Pharmaceutical shares held by Zhonghuiyuan.

This transaction is a normal business arrangement for the company to optimize subsidiary governance and deepen its industrial layout. It aligns with the company's overall strategic development plan and serves the company's long-term development interests as well as the overall interests of all shareholders.

The transaction will not result in any significant changes to the company's current or future financial condition and operating results, nor will it have any adverse impact on the company's daily operations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10